E-DRUG: TODAY: Reminder Webinar Dec 15 - Biosecurity R&D: lessons from U.S. pre-Covid to post-Covid
--------------------------------------------------------------------------
Dear all,
Just a quick reminder that the webinar below is taking place Wednesday
(today), December 15, 4 pm CET. For those who can't join live, the
recording will be made available at
https://www.knowledgeportalia.org/webinars.
Biosecurity R&D: lessons from the U.S. from pre-Covid to post-Covid
Wednesday, December 15, 4pm - 5pm CET
To join the webinar, please register here:
https://us02web.zoom.us/webinar/register/8016395052399/WN_ua3SXlvQTXWYOoC4OX7ZtQ
Speakers:
Joseph Larsen, Vice President, Strategic Portfolio Development, Venatorx
Pharmaceuticals. Former Deputy Director, Division of CBRN Medical
Countermeasures, Biomedical Advanced Research and Development Authority
(BARDA)
Daniel P. Gross, Assistant Professor, Duke University Fuqua School of
Business, and Faculty Research Fellow, National Bureau of Economic Research
Research:
Larsen, Joseph C., and Gary L. Disbrow. 2017. 'Project BioShield and the
Biomedical Advanced Research Development Authority: A 10-Year Progress
Report on Meeting US Preparedness Objectives for Threat Agents'. Clinical
Infectious Diseases, Volume 64, Issue 10, https://doi.org/10.1093/cid/cix097
Gross, Daniel P., and Bhaven N. Sampat. 2021. 'Crisis Innovation Policy
from World War II to COVID-19'. Forthcoming in NBER Entrepreneurship and
Innovation Policy and the Economy. Cambridge, MA: National Bureau of
Economic Research. https://doi.org/10.3386/w28915.
Sunyoto, Temmy, Marcela Vieira, Suerie Moon, and Anna Bezruki. 2020.
Research Synthesis: Biosecurity R&D.â Knowledge Portal on Innovation and
Access to Medicines , Global Health Centre, Graduate Institute of Geneva.
https://www.knowledgeportalia.org/biosecurityrd.
Covid-19 has prompted heightened interest in how to ensure research,
development (R&D) and access to medical countermeasures - that is, health
technologies such as drugs, vaccines, diagnostics - for preparedness and
response to pandemics. The United States has an established and extensive
innovation system directed at the development of medical countermeasures,
and analysing its successes and shortcomings can provide valuable insights
for other countries and regions, as well as for current debates on how to
reform the global system. Joseph Larsen will reflect on the Biomedical
Advanced Research and Development Authority (BARDA) experience developing
and procuring medical countermeasures based on 10 years experience
pre-Covid, and how it has impacted the United State's preparedness and
response to public health emergencies. Daniel P. Gross will further
describe U.S. crisis innovation policy, analysing similarities and
differences between approaches taken in World War II and the COVID-19
pandemic, with insights into the long-term impacts of crises on the
innovation system more broadly and lessons for innovation policy in both
crises and regular times.
The webinar is free and open to the public and will be held in English.
Participants can pose questions orally or in writing, and the speakers will
respond to a selection of these during the second half of the event.
Recordings of all webinars are made available at the Knowledge Portal on
Innovation and Access to Medicines. After registering, you will receive a
confirmation email with additional information on how to join the webinar
using the Zoom platform. This event is part of the webinar series of the
Knowledge Network for Innovation and Access to Medicines, Global Health
Centre, Graduate Institute of Geneva.
Marcela Vieira, LLB, MPH
Lead Researcher and Project Lead
New Business Models for Governing Innovation and Global Access to Medicines
Coordinator of the
Knowledge Network for Innovation and Access to Medicines
https://www.knowledgeportalia.org/
Global Health Centre, Research
Graduate Institute of International and Development Studies
marcela.vieira@graduateinstitute.ch